Search research articles
Contact Us
Filters
Showing results (41-50 of 251) with videos related to
Page
of 26
Sort By:
Drugs
|
April 1, 1984
Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy
C e Eiriksson, R N Brogden
Drugs
|
April 1, 1993
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
H M Bryson, R N Brogden
Drugs
|
November 1, 1988
Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease
A H Price, R N Brogden
Drugs
|
December 1, 1991
Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist
R N Brogden, K L Goa
Drugs
|
June 1, 1989
Muromonab CD3. A review of its pharmacology and therapeutic potential
P A Todd, R N Brogden
Drugs
|
June 1, 1985
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
S P Clissold, R N Brogden
Drugs
|
January 1, 1997
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management
J C Gillis, R N Brogden
Drugs
|
November 7, 1998
Topotecan. A review of its potential in advanced ovarian cancer
R N Brogden, L R Wiseman
Drugs
|
April 30, 1998
Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis
A J Coukell, R N Brogden
Drugs
|
June 9, 1998
Moexipril. A review of its use in the management of essential hypertension
R N Brogden, L R Wiseman
Page
of 26
Search research articles
Search
Showing results (41-50 of 251) with videos related to
Sort By:
Page
of 26
Drugs
|
April 1, 1984
Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy
C e Eiriksson, R N Brogden
Drugs
|
April 1, 1993
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
H M Bryson, R N Brogden
Drugs
|
November 1, 1988
Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease
A H Price, R N Brogden
Drugs
|
December 1, 1991
Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist
R N Brogden, K L Goa
Drugs
|
June 1, 1989
Muromonab CD3. A review of its pharmacology and therapeutic potential
P A Todd, R N Brogden
Drugs
|
June 1, 1985
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
S P Clissold, R N Brogden
Drugs
|
January 1, 1997
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management
J C Gillis, R N Brogden
Drugs
|
November 7, 1998
Topotecan. A review of its potential in advanced ovarian cancer
R N Brogden, L R Wiseman
Drugs
|
April 30, 1998
Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis
A J Coukell, R N Brogden
Drugs
|
June 9, 1998
Moexipril. A review of its use in the management of essential hypertension
R N Brogden, L R Wiseman
Page
of 26